This timely webinar will review the pharmaceutical services CMS Conditions of Participation and other regulatory areas that require pharmacist input and participation, including: Antibiotic stewardship Medication administration timing policies Self-administration of medicine Standing orders Additionally, the program will address medication errors, adverse events, drug incompatibilities, and the necessary policies that promote patient safety
McCarthy C, Wong MC, Brown J, Ramirez S, Yang S, Bennett JP, et al
Zhang Y, Li X, Li S, Zhou Y, Zhang T, Sun L
Video Endoscopic Sequence 3 of 7
If you are considering switching from tirzepatide to semaglutide or moving to a different agent, discuss the specific digestive side effect profile with your provider
The CEO of Eli Lilly notes that because orforglipron is less complex, it may be less expensive to manufacture than injectable GLP-1s, potentially improving affordability